R Baker. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » AIDS-Related Opportunistic Infections/complicationsAIDS-Related Opportunistic Infections/drug therapyAmphotericin B/administration & dosageAmphotericin B/adverse effectsAmphotericin B/therapeutic useAntifungal Agents/administration & dosageAntifungal Agents/adverse effectsAntifungal Agents/therapeutic useAntineoplastic Agents/administration & dosageAntineoplastic Agents/adverse effectsAntineoplastic Agents/therapeutic useAspergillosis/complicationsAspergillosis/drug therapyDoxorubicin/administration & dosageDoxorubicin/adverse effectsDoxorubicin/therapeutic useDrug ApprovalDrug CarriersHumansLiposomesSarcoma, Kaposi/drug therapySarcoma, Kaposi/etiologyUnited StatesUnited States Food and Drug Administration
Substances: See more » Antifungal AgentsAntineoplastic AgentsDrug CarriersLiposomesAmphotericin BDoxorubicin
Year: 1995 PMID: 11363009
Source DB: PubMed Journal: BETA ISSN: 1058-708X